- Joined
- May 14, 2009
- Messages
- 10,350
- Reaction score
- 4,989
- Gender
- Male
- Political Leaning
- Other
About time this becomes widely available for about what it sells for in Europe
And also shows Mylan's Fraudulent cost numbers.
My guess is they're still making at last 50% profit even at 109.
(MW's title line seems redundant to me. Should have stopped with "...Version.")
CVS takes on Mylan's EpiPen with much cheaper version of an alternative - MarketWatch
CVS Drugstore chain is offering generic of Impax Labs Adrenaclick for a Sixth of the price of the EpiPen
takes on Mylan’s EpiPen with much cheaper version of an alternative
By Ciara Linnane
Published: Jan 15, 2017 12:01 p.m. ET
And also shows Mylan's Fraudulent cost numbers.
My guess is they're still making at last 50% profit even at 109.
(MW's title line seems redundant to me. Should have stopped with "...Version.")
CVS takes on Mylan's EpiPen with much cheaper version of an alternative - MarketWatch
CVS Drugstore chain is offering generic of Impax Labs Adrenaclick for a Sixth of the price of the EpiPen
takes on Mylan’s EpiPen with much cheaper version of an alternative
By Ciara Linnane
Published: Jan 15, 2017 12:01 p.m. ET
CVS said Thursday it is now offering a low-cost treatment for life-threatening allergies, after an outcry about the high cost of the best-selling product in the category, Mylan Inc.'s EpiPen.
CVS (CVS) said it is selling the authorized generic for Adrenaclick, an alternative to the EpiPen, that is made by Impax Laboratories Inc. (IPXL), priced at $109.99 for a two-pack.
That compares with the $649.99 cash price of an EpiPen and the $339.99 being charged for its authorized generic. Adrenaclick is an epinephrine auto-injector that was approved by the U.S. Food and Drug Administration in 2003.
[......]
Last edited: